Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.
By Shao‐Liang Chen, Wu-wang Fang, F. Ye, Yu-hao Liu, J. Qian, Shou‐jie Shan, Junjie Zhang, Robert Zhao Chunhua, L. Liao, Song Lin and 1 more. American Journal of Cardiology, 2004
1,225 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Genetics, Surgery
View Paper: https://www.semanticscholar.org/paper/a555f7a3bbeb87a92cb6d15eb1d2bd8ac685c34e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Surgery
Citations in the corpus
- Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. (2005, background): “Due to their accessibility, expandability, and multipotentiality, MSC hold promise for clinical applications [27–37].”
- Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages (2009, background): “In many phase I and II clinical studies MSCs, autologous or allogeneic, have been shown to be potentially efficacious for treatment of a wide variety of clinical conditions such as acute graft versus host disease after allogeneic hematopoietic stem cell transplantation [40,41], myocardial, infarctio”
- Ethical and Safety Issues of Stem Cell-Based Therapy (2018, background): “Several studies have examined therapeutic potential of autologous and allogeneic MSCs in the treatment of acute myocardial infarction (MI) [66-70].”
- From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells (2007, background): “…such as the bone marrow stromal stem cells, stromal precursor cells, recycling stem cells, marrow isolated adult multineage inducible stem cells (MIAMI cells), and multi-potent adult progenitor cells (MAPC) (Reyes et al., 2001; D’Ippolito et al., 2004; Beyer Nardi and da Silva Meirelles, 2006).”
- Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “Mohyeddin-Bonab et al. investigated the therapeutic effi-cacy of autologous BM-MSCs in 16 patients with old MI undergoing coronary artery bypass grafting or PCI [194].”